COVID-19 vaccines' global return on investment measured for first year of rollout
COVID-19 vaccines' global return on investment measured for first year of rollout
COVID-19 vaccines' global return on investment measured for first year of rollout
Key points
اہم نکات
मुख्य बातें
- A new study has measured the global return on investment from COVID-19 vaccines in the first year of the vaccination programme.
- The model-based economic evaluation, published in PLOS, weighs what the vaccines cost against the health and economic harm they helped avoid.
- The research offers one of the fullest pictures yet of what the first year of vaccination was worth to the world economy.
- A new study has measured the global return on investment from COVID-19 vaccines in the first year of the vaccination programme.
- The model-based economic evaluation, published in PLOS, weighs what the vaccines cost against the health and economic harm they helped avoid.
- The research offers one of the fullest pictures yet of what the first year of vaccination was worth to the world economy.
- A new study has measured the global return on investment from COVID-19 vaccines in the first year of the vaccination programme.
- The model-based economic evaluation, published in PLOS, weighs what the vaccines cost against the health and economic harm they helped avoid.
- The research offers one of the fullest pictures yet of what the first year of vaccination was worth to the world economy.
A new study has measured the global return on investment from COVID-19 vaccines in the first year of the vaccination programme. The model-based economic evaluation, published in PLOS, weighs what the vaccines cost against the health and economic harm they helped avoid. The research offers one of the fullest pictures yet of what the first year of vaccination was worth to the world economy.
A new study has measured the global return on investment from COVID-19 vaccines in the first year of the vaccination programme. The model-based economic evaluation, published in PLOS, weighs what the vaccines cost against the health and economic harm they helped avoid. The research offers one of the fullest pictures yet of what the first year of vaccination was worth to the world economy.
A new study has measured the global return on investment from COVID-19 vaccines in the first year of the vaccination programme. The model-based economic evaluation, published in PLOS, weighs what the vaccines cost against the health and economic harm they helped avoid. The research offers one of the fullest pictures yet of what the first year of vaccination was worth to the world economy.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।